STOCK TITAN

Inflection Point Acquisition V (IPEX) Stock Price, News & Analysis

IPEX

Inflection Point Acquisition V (IPEX) last traded on September 25, 2026. A Form 15-12G filed on October 5, 2026 ends the SEC registration of its shares.

Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
12 184 sessions, November 25, 2025 to September 25, 2026
Largest daily move
-57.8% close of September 25, 2026
1-month change
-70% closing prices, August 25, 2026 to September 25, 2026

Company Description

Inflection Point Acquisition V (IPEX) is classified in the shell companies industry within the Financial Services sector.

IPEX declined 69.3% in the year to September 25, 2026. The last closing price was $3.16.

For FY2025, Inflection Point Acquisition V reported net income of $397K.

This page collects what Stock Titan holds for IPEX, including price data, latest news, SEC filings, financial highlights, and short interest trends.

Stock Performance

$3.16
No recent trading
Last close: September 25, 2026
-69.3%
Year to September 25, 2026

Inflection Point Acquisition V (IPEX) closed at $3.16 on September 25, 2026. In the year to September 25, 2026, the price lost 69.3%.

See what a $1,000 investment in IPEX would be worth today

Average down calculator for IPEX

IPEX Metrics & Rankings

Price returns through September 25, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

Inflection Point Acquisition V has 1 recent news article. Of the recent coverage, 0 articles coincided with positive price movement and 1 with negative movement. View all IPEX news →

Financial Highlights

Inflection Point Acquisition V reported operating income of -$2.7M in FY2025, and net income was $397K. The company generated -$701K in operating cash flow. The current ratio was 0.08, measuring current assets divided by current liabilities.

$397K
Net Income (FY2025)
-$701K
Operating Cash Flow
—
Revenue (FY2025)

Upcoming Events

No upcoming events scheduled for IPEX.

Short Interest History

Last 12 Months

Short interest in Inflection Point Acquisition V (IPEX) currently stands at 33.8 thousand shares, up 867.1% from the previous reporting period, representing 2.6% of the float. Since November 2025, short interest has increased by 1732.4%.

Days to Cover History

Last 12 Months

Days to cover for Inflection Point Acquisition V (IPEX) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume.

IPEX Company Profile & Sector Positioning

Inflection Point Acquisition V (IPEX) operates in the Shell Companies industry within the broader Financial Services sector.

Investors comparing IPEX often look at related companies in the same sector, including Drugs Made In America Acquisition II Corp. (DMII), Churchill Capital Corp XI (CCXI), EQV Ventures Acquisition Corp. II (EVAC), Bain Capital GSS Investment Corp. (BCSS), and Cantor Equity Partners IV, Inc. (CEPF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate IPEX's relative position within its industry.

Frequently Asked Questions

Inflection Point Acquisition V (IPEX) last traded on September 25, 2026. A Form 15-12G filed on October 5, 2026 ends the SEC registration of its shares.

Inflection Point Acquisition V (IPEX) has no recent trading. Its last close was $3.16 on September 25, 2026.

The FY2025 net income of Inflection Point Acquisition V (IPEX) is $397K, from its most recent completed fiscal year.

The operating cash flow of Inflection Point Acquisition V (IPEX) is -$701K for FY2025, its most recent completed fiscal year. Learn about cash flow.

The current ratio of Inflection Point Acquisition V (IPEX), current assets divided by current liabilities, was 0.08 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The operating income of Inflection Point Acquisition V (IPEX) is -$2.7M for FY2025, its most recent completed fiscal year. Learn about operating income.